Radiopharm Theranostics (RADX) Accumulated Expenses (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Accumulated Expenses for 1 consecutive years, with $450104.0 as the latest value for Q2 2025.
- On a quarterly basis, Accumulated Expenses changed N/A to $450104.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $450104.0, a N/A change, with the full-year FY2025 number at $450104.0, changed N/A from a year prior.
- Accumulated Expenses was $450104.0 for Q2 2025 at Radiopharm Theranostics.
- In the past five years, Accumulated Expenses ranged from a high of $450104.0 in Q2 2025 to a low of $450104.0 in Q2 2025.